Go to main page

Symposium: Innovative Approaches to Accelerating Drug Discovery and Development

Thursday, June 14, 2018

San Diego, CA

Register Today!
pic1

How can we accelerate successful drug discovery and development?

The success of clinical candidate development depends on several factors, important among them are generation of novel, therapeutically-relevant chemical structures, early and rapid assessment of possible efficacy of candidate structures in pre-clinical therapeutic models and rapid elimination of candidates that will ultimately prove unsuccessful. Innovative processes and techniques that facilitate optimal candidate selection is a crucial step in accelerating drug discovery and development timelines.

Join us on Thursday, June 14, 2018 for an afternoon of lunch, insightful presentations and discussion, followed by a networking and happy hour reception.

11:30 AM- 12:30 PM

Registration & Lunch, Opening Remarks

12:30 PM- 4:50 PM

Speakers

4:50 PM- 5:00 PM

Closing Remarks

5:00 PM- 6:00 PM

Networking Reception and Happy Hour

Registration for this event is free, but space is limited. RSVP here!

We look forward to seeing you in San Diego!

Event Details

Date:

Thursday, June 14, 2018
11:30 AM- 6:30 PM PDT

 

Location:

Farmer & the Seahorse
10996 Torreyana Rd
San Diego, CA 92121

Registration:

This event is free to attend, but space is limited. Reserve a seat today!

Speakers

Why Bother? Impact of Downstream Development and Market Considerations on Discovery Projects

Vince Wacher, Ph. D. | Product Planning and Development

The ReFRAME Drug Repositioning Library: Building and Applications to Neglected Diseases

Arnab Chatterjee, Ph. D. | VP Medicinal Chemistry | Calibr

Paving the Road to the Clinic: Advancing Oncology Drug Development with Translational In Vitro and In Vivo Models

Tommy Broudy, Ph. D. | CEO | Molecular Response

BioDuro Solution Engine: Enabled Formulations Bridging Discovery and Development

Blair West, Ph. D. | CSO, Global CMC Solutions | BioDuro

Development of Poorly Soluble Compounds: Discovery to FIH and Later Clinical Development Phases

Hamid Rezai, Ph. D. | Senior Director of Pharmaceutics | Plexxikon Inc.

Reactive Melt Extrusion to Improve Properties of Amorphous Solid Dispersions

Feng Zhang, Ph. D. | Assistant Professor of Pharmaceutics | University of Texas at Austin

If you have any questions about this event, please contact us directly.